Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres

Journal of Cystic Fibrosis

Volumn 9, Issue 2, 2010, Pages 104-109

  Doe, S J ^a,b   McSorley, A ^a,b   Isalska, B ^a,b   Kearns, A M ^a,b   Bright Thomas, R ^a,b   Brennan, A L ^a,b   Webb, A K ^a,b   Jones, A M ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotics; Cross infection; Cystic fibrosis; Eradication; Infection control; MRSA

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; FUSIDIC ACID; PSEUDOMONIC ACID; RIFAMPICIN; TRICLOSAN; TRIMETHOPRIM; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL TRANSMISSION; CHEST TIGHTNESS; CONTROLLED STUDY; CROSS INFECTION; CYSTIC FIBROSIS; DIARRHEA; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; ERADICATION THERAPY; FOLLOW UP; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; NONHUMAN; PREVALENCE; REINFECTION; RISK FACTOR; THROMBOCYTOPENIA; VOMITING;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; COHORT STUDIES; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFECTION CONTROL; INPATIENTS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ISOLATION; PREVALENCE; RETREATMENT; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749131586     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.11.009     Document Type: Article

References (29)

1. Gould F.K., Brindle R., Chadwick P.R., Fraise A.P., Hill S.P., et al. Guideline for the prophylaxis and treatment of methicillin resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrobial Chemother 63 5 (2009) 849-861
2. Consensus report. MRSA in cystic fibrosis. J Hosp Infect 40 (1998) 179-191
3. Boxerbaum B., Jacobs M.R., and Cechner R.L. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol 4 3 (1988) 159-163 Erratum in: Pediatr Pulmonol 1988;5(1):66
4. Sawicki G.S., Rasouliyan L., Pasta D.J., Regelmann W.E., Wagener J.S., Waltz D.A., et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol 43 11 (2008) 1117-1123
5. Cystic Fibrosis Foundation. Patient Registry 2007 annual report (2008), Cystic Fibrosis Foundation, Bethesda, MD
6. Cystic Fibrosis Foundation. Patient Registry 2002 annual report (2003), Cystic Fibrosis Foundation, Bethesda MD
7. UK Cystic Fibrosis Trust Infection Control Working Group. Methicillin resistant Staphylococcus aureus (MRSA). 2008. UK CF Trust. Ref Type: Report.
8. Givney R., Vickery A., Holliday A., Pegler M., and Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit. J Hosp Infect 35 1 (1997) 27-36
9. Ren C.L., Morgan W.J., Konstan M.W., Schechter M.S., Wagener J.S., Fisher K.A., et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 42 6 (2007) 513-518
10. Miall L.S., McGinley N.T., Brownlee K.G., and Conway S.P. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child 84 2 (2001) 160-162
11. Thomas S.R., Gyi K.M., Gaya H., and Hodson M.E. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect 40 3 (1998) 203-209
12. Dasenbrook E.C., Merlo C.A., Diener-West M., Lechtzin N., and Boyle M.P. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 178 8 (2008) 814-821
13. Macfarlane M., Leavy A., McCaughan J., Fair R., and Reid A.J. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. J Hosp Infect 65 3 (2007) 231-236
14. Solís A., Brown D., Hughes J., Van Saene H.K., and Heaf D.P. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol 36 3 (2003) 189-195
15. Máiz L., Cantón R., Mir N., Baquero F., and Escobar H. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol 26 4 (1998) 287-289
16. Serisier D.J., Jones G., and Carroll M. Eradication of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis with linezolid. J Cyst Fibros 3 1 (2004) 61
17. Garske L.A., Kidd T.J., Gan R., Bunting J.P., Franks C.A., Coulter C., et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect 56 3 (2004) 208-214
18. Ferrin M., Zuckerman J.B., Meagher A., and Blumberg E.A. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Pediatr Pulmonol 33 3 (2002) 221-223
19. Kappler M., Felicke M., Schweiger-Kabesch, Schroter C., Liese J., Ripper J., et al. Eradication of methicillin resistant Staphylococcus aureus in cystic fibrosis. J Cyst Fibros 8 Suppl 2 (2009) abstract 170
20. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., and Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43 (2005) 2384-2390
21. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358 (2001) 557-558
22. McCallum S.J., Corkill J., Gallagher M., Ledson M.J., Hart C.A., and Walshaw M.J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358 (2001) 558-560
23. Saiman L., Seigel J., and and the Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient to patient transmission. Infect Control Hosp Epidemiol 24 Suppl 5 (2003) S6-S52
24. Zhou J., Garber E., and Saiman L. Survey of infection control policies for patients with cystic fibrosis in the United States. Am J Infect Control 36 3 (2008) 220-222
25. Molina A., Del Campo R., Máiz L., Morosini M.I., Lamas A., Baquero F., et al. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother 62 5 (2008) 961-967
26. Kidd T.J., Coulter C., and Bell S.C. Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 27 2 (2006) 201-203
27. Glikman D., Siegel J.D., David M.Z., Okoro N.M., Boyle-Vavra S., Dowell M.L., et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest 133 6 (2008) 1381-1387
28. Downey D.G., Kidd T.J., Coulter C., and Bell S.C. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. J Cyst Fibros 4 3 (2005) 205-207
29. Elizur A., Orscheln R.C., Ferkol T.W., Atkinson J.J., Dunne Jr. W.M., Buller R.S., et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 131 6 (Jun 2007) 1718-1725